publicações selecionadas
-
artigo académico
- Recent Advances in the Selection of Cancer-Specific Aptamers for the Development of Biosensors. Current Medicinal Chemistry. 2022
- In Vitro CRISPR/Cas9 Transfection and Gene-Editing Mediated by Multivalent Cationic Liposome-DNA Complexes. Pharmaceutics. 2022
- In Vitro CRISPR/Cas9 Transfection and Gene-Editing Mediated by Multivalent Cationic Liposome-DNA Complexes. Pharmaceutics. 2022
- In vitro selection of DNA aptamers against human osteosarcoma. Investigational New Drugs. 2022
- In vitro selection of DNA aptamers against human osteosarcoma. Investigational New Drugs. 2022
- Identification of novel aptamers targeting Cathepsin B-overexpressing prostate cancer cells. Molecular Systems Design & Engineering. 2022
- Selection of aptamers against triple negative breast cancer cells using high throughput sequencing. Acta Cytologica. 2021
-
artigo de conferência
-
documento
- Smart extracellular vesicles for targeted therapy in breast cancer 2025
- Development of targeted delivery platforms against highly metastatic cancers 2022
- Non-viral delivery of CRISPR/Cas9 DNA for gene editing via multivalent cationic liposome system 2022
- Cellular delivery of CRISPR/Cas9 plasmid using multivalent cationic liposomes 2021
- In silico prediction and design of CRISPR sgRNAs targeting miR-155 for TNBC treatment 2020
- Targeting oncogenic microRNAs in triple negative breast cancer using a CRISPR/Cas9-based approach 2020
- CRISPR/Cas9-mediated knockout of miR-155 for Triple Negative Breast Cancer treatment 2020
- Chapter 14 - Nanotechnology in targeted drug delivery and therapeutics 2019
- Targeting oncogenic microRNAs in triple negative breast cancer using CRISPR/cas9 approach 2018
- Selection of a molecule that specifically targets the cell-surface Human Epidermal growth factor Receptor 2: in silico docking simulation 2017
- In silico selection of an ssDNA aptamer against HER2-positive breast cancer cells using computational docking simulation 2017